TABLE 2.

Outcomes and major adverse events, n=678 patients

Adverse Event	N (%)
Major Adverse Events
Acute lung injury	104 (15.3)
Acute kidney injury	159 (23.5)
Acute respiratory distress syndrome	94 (13.9)
Deep vein thrombosis	49 (7.2)
Infectiona	204 (30.1)
Multiple organ failure	35 (5.2)
Myocardial infarction	2 (0.3)
Pulmonary embolism, asymptomatic	22 (3.2)
Pulmonary embolism, symptomatic	27 (4.0)
Sepsis	190 (28.0)
Stroke	19 (2.8)
Ventilator-associated pneumonia	120 (17.7)
Transfusion-associated circulatory overload	1 (0.2)
Transfusion-related metabolic complicationb	112 (16.5)
Rhabdomyolysis	18 (2.7)
24-Hour Death	100 (14.8)
≥2 Adverse Events	195 (43.5)
24-Hour Death or ≥2 Adverse Events	387 (57.1)
30-Day Death	164 (24.2)c

^aIncludes urinary tract infection, wound infection, line infection, etc.

^bIncludes hypocalcemia, hyperkalemia

^c30-day status not known for 4 subjects